Q1 2025 · 13F-HR
BROADWOOD CAPITAL INCholdings as filed
Filed 2025-05-15 · accession 0000919574-25-003088
$1.23B
Reported value
8
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 61174X109 | MNST | MONSTER BEVERAGE CORP NEW | $485.5M | 39.3% | 8,295,690 | Common | SOLE |
| 05464C101 | AXON | AXON ENTERPRISE INC | $366.1M | 29.7% | 696,075 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $219.6M | 17.8% | 12,455,264 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $94.7M | 7.67% | 474,920 | Common | SOLE |
| 68235C206 | IMDX | ONCOCYTE CORP | $34.9M | 2.83% | 11,410,100 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $22.4M | 1.81% | 49,560,992 | Common | SOLE |
| 68134L109 | OLOGBX | OLO INC | $10.8M | 0.87% | 1,782,334 | Common | SOLE |
| 81751A108 | SER | SERINA THERAPEUTICS INC | $483,192 | 0.04% | 85,219 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.